Different hCG assays to measure ectopic hCG secretion in bladder carcinoma patients
1996

Measuring hCG in Bladder Cancer Patients

Sample size: 33 publication Evidence: moderate

Author Information

Author(s): J Moral, N Gascon, JMa Tabernero, J Rodriguez-Espinosal, F Gonzalez-Sastre

Primary Institution: Hospital de Sant Pau

Hypothesis

Different hCG assays will have varying diagnostic sensitivities in bladder carcinoma patients with ectopic hCG secretion.

Conclusion

The study found that t-hCG and free β-hCG assays are the most suitable for managing bladder carcinoma patients.

Supporting Evidence

  • The diagnostic sensitivity of t-hCG assays ranged from 63.6% to 75.7%.
  • Free β-hCG assay had a diagnostic sensitivity of 72.7%.
  • i-hCG assay had a sensitivity of only 6%.
  • Median increases of hCG during treatment ranged from 4.9 to 6.9 for t-hCG and free β-hCG assays.

Takeaway

Doctors tested different ways to measure a hormone called hCG in bladder cancer patients, and found that some tests work better than others.

Methodology

The study evaluated various hCG assays in bladder carcinoma patients at diagnosis and during treatment.

Limitations

The study focused on patients with raised hCG values, which may not represent the general population.

Participant Demographics

33 bladder carcinoma patients, 30 men and 3 women, aged 42-75 years.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication